Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03611335 · ClinicalTrials.gov registry record
A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 90
- Enrollment target
NCT03611335: Completed study, sponsored by NYU Langone Health.
NCT03611335 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03611335 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This pragmatic clinical trial seeks to evaluate the effectiveness of the Consult for Addiction Treatment and Care in Hospitals (CATCH) intervention as a strategy for engaging patients with Opiod Use Disorder (OUD) in addiction treatment.
Primary Outcome
Effectiveness of patients hospitalized during the CATCH period to have higher rates of treatment initiation.
Interventions
- BEHAVIORAL CATCH Interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-12-07 |
| Est. Completion | 2023-03-20 |
What the finished NCT03611335 record still lists
NCT03611335 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CATCH Interviews is the first listed.
NCT03611335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03611335 about?
NCT03611335 is a clinical study titled "A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment". This pragmatic clinical trial seeks to evaluate the effectiveness of the Consult for Addiction Treatment and Care in Hospitals (CATCH) intervention as a strategy for engaging patients with Opiod Use Disorder (OUD) in addiction treatment.
What is the current status of trial NCT03611335?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2018-12-07. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT03611335?
The interventions under investigation include: CATCH Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT03611335?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI